Skip to main content
Clinical Case Reports logoLink to Clinical Case Reports
. 2019 May 10;7(5):1114. doi: 10.1002/ccr3.2118

BCR‐ABL exon 7 deletion and novel point mutation in patient with chronic myelogenous leukemia

PMCID: PMC6509890  PMID: 31110760

AUTHORSHIP LIST

1. Adhamjon Abdullaev, MD, PhD, Senior Research Scientist

Molecular Hematology Department, National Research Center for Hematology, Moscow, Russia.

Authorship: Designed and performed sequencing experiments, analyzed the data, and interpreted the results.

Email: adham_abdullaev@mail.ru

2. Irina Nemchenko, MD, PhD, Senior Research Scientist

Department of Chemotherapy of Myeloproliferative disorders, National Research Center for Hematology, Moscow, Russia.

Authorship: Involved in patient management and follow‐up, analysis of clinical data.

Email: isn1965@mail.ru

3. Olga Nesterova, Undergraduate Student, Faculty of Fundamental Medicine, Lomonosov Moscow State University

Authorship: Interpreted the results.

Email: oy.nesterova@gmail.com

4. Ilya Mikhailov, Undergraduate Student, Faculty of Fundamental Medicine, Lomonosov Moscow State University

Authorship: Wrote and submitted the manuscript.

Email: ilyamikhailov5@gmail.com

5. Andrey Sudarikov, PhD, DSc, Head of Molecular Hematology Department

Authorship: Contributed to the design of the research and data analysis.

Email: dusha@blood.ru

Mikhailov I. (2018) BCR‐ABL exon 7 deletion and novel point mutation in patient with chronic myelogenous leukemia and TKI resistance. Clin Case Rep, 6: 2057‐2060. https://doi.org/10.1002/ccr3.1794


Articles from Clinical Case Reports are provided here courtesy of Wiley

RESOURCES